Insurers Blast CMS Transparency Rule; ACHP Offers Alternative
Organizations representing health insurers are blasting the Trump administration’s proposed insurer price transparency regulations, saying the rule is anti-competitive and could even force prices higher.
In written comments on the rule to CMS Administrator Seema Verma, health insurer trade groups said they agreed in principle that transparency is good, but the administration’s approach — released in its proposed rule last fall (HPW 11/25/19, p. 1) — is too heavy-handed. “The plans are not opposed to getting consumers the information that they need to make decisions about benefits,” says Dan Mendelson, Avalere founder and former CEO. “But there are a couple of issues here that are causing the plans to oppose this particular rule.”